K284-5066 Screening compound: 2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

K284-5066 Screening compound: 2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide
K284-5066 Screening compound: 2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K284-5066
2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-5066

Molecular Formula

C27H30N4O6S2 (C27 H30 N4 O6 S2)

Compound Name

2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

IUPAC name

2-({7-[2-(cyclohex-1-en-1-yl)ethyl]-8-oxo-2H7H8H-[13]dioxolo[45-g]quinazolin-6-yl}sulfanyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide

SMILES

NS(c1ccc(CCNC(CSC(N2CCC3=CCCCC3)=Nc(cc3OCOc3c3)c3C2=O)=O)cc1)(=O)=O

InChI

InChI=1S/C27H30N4O6S2/c28-39(34,35)20-8-6-19(7-9-20)10-12-29-25(32)16-38-27-30-22-15-24-23(36-17-37-24)14-21(22)26(33)31(27)13-11-18-4-2-1-3-5-18/h4,6-9,14-15H,1-3,5,10-13,16-17H2,(H,29,32)(H2,28,34,35)

InChI Key

AQVIERBFNDUVJO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15088629

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

570.69

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.905

Distribution Coefficient, logD

2.904

Water Solubility, LogSw

-3.75

Polar Surface Area

117.973

Acid Dissociation Constant (pKa)

10.18

Base Dissociation Constant (pKb)

0.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

K284-5066 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with K284-5066 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K284-5066?
Check Price and Availability of K284-5066, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K284-5066 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K284-5066
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K284-5066
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K284-5066 available by request